BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33095152)

  • 1. Systemic phenotype related to primary Sjögren's syndrome in 279 patients carrying isolated anti-La/SSB antibodies.
    Acar-Denizli N; Horváth IF; Mandl T; Priori R; Vissink A; Hernandez-Molina G; Armagan B; Praprotnik S; Sebastian A; Bartoloni E; Rischmueller M; Pasoto SG; Nordmark G; Nakamura H; Fernandes Moça Trevisani V; Retamozo S; Carsons SE; Maure-Noia B; Sánchez-Berná I; López-Dupla M; Fonseca-Aizpuru E; Melchor Díaz S; Vázquez M; Díaz Cuiza PE; de Miguel Campo B; Ng WF; Rasmussen A; Dong X; Li X; Baldini C; Seror R; Gottenberg JE; Kruize AA; Sandhya P; Gandolfo S; Kwok SK; Kvarnstrom M; Solans R; Sene D; Suzuki Y; Isenberg DA; Valim V; Hofauer B; Giacomelli R; Devauchelle-Pensec V; Atzeni F; Gheita TA; Morel J; Izzo R; Kalyoncu U; Szántó A; Olsson P; Bootsma H; Ramos-Casals M; Kostov B; Brito-Zerón P;
    Clin Exp Rheumatol; 2020; 38 Suppl 126(4):85-94. PubMed ID: 33095152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients.
    Retamozo S; Acar-Denizli N; Rasmussen A; Horváth IF; Baldini C; Priori R; Sandhya P; Hernandez-Molina G; Armagan B; Praprotnik S; Kvarnstrom M; Gerli R; Sebastian A; Solans R; Rischmueller M; Pasoto SG; Valim V; Nordmark G; Kruize A; Nakamura H; Hofauer B; Giacomelli R; Fernandes Moça Trevisani V; Devauchelle-Pensec V; Atzeni F; Gheita TA; Consani-Fernández S; Szántó A; Sivils K; Gattamelata A; Danda D; Kilic L; Bartoloni E; Bombardieri S; Sánchez-Guerrero J; Wahren-Herlenius M; Mariette X; Ramos-Casals M; Brito-Zerón P;
    Clin Exp Rheumatol; 2019; 37 Suppl 118(3):97-106. PubMed ID: 31464664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sjögren's syndrome.
    Brito-Zerón P; Acar-Denizli N; Ng WF; Horváth IF; Rasmussen A; Seror R; Li X; Baldini C; Gottenberg JE; Danda D; Quartuccio L; Priori R; Hernandez-Molina G; Armagan B; Kruize AA; Kwok SK; Kvarnstrom M; Praprotnik S; Sene D; Gerli R; Solans R; Rischmueller M; Mandl T; Suzuki Y; Isenberg D; Valim V; Wiland P; Nordmark G; Fraile G; Bootsma H; Nakamura H; Giacomelli R; Devauchelle-Pensec V; Hofauer B; Bombardieri M; Trevisani VFM; Hammenfors D; Pasoto SG; Retamozo S; Gheita TA; Atzeni F; Morel J; Vollenweider C; Zeher M; Sivils K; Xu B; Bombardieri S; Sandhya P; De Vita S; Minniti A; Sánchez-Guerrero J; Kilic L; van der Heijden E; Park SH; Wahren-Herlenius M; Mariette X; Ramos-Casals M;
    Rheumatology (Oxford); 2020 Sep; 59(9):2350-2359. PubMed ID: 31873754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project).
    Brito-Zerón P; Acar-Denizli N; Ng WF; Zeher M; Rasmussen A; Mandl T; Seror R; Li X; Baldini C; Gottenberg JE; Danda D; Quartuccio L; Priori R; Hernandez-Molina G; Armagan B; Kruize AA; Kwok SK; Kvarnström M; Praprotnik S; Sène D; Bartoloni E; Solans R; Rischmueller M; Suzuki Y; Isenberg DA; Valim V; Wiland P; Nordmark G; Fraile G; Bootsma H; Nakamura T; Giacomelli R; Devauchelle-Pensec V; Knopf A; Bombardieri M; Trevisani VF; Hammenfors D; Pasoto SG; Retamozo S; Gheita TA; Atzeni F; Morel J; Vollenveider C; Horvath IF; Sivils KL; Olsson P; De Vita S; Sánchez-Guerrero J; Kilic L; Wahren-Herlenius M; Mariette X; Ramos-Casals M;
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):102-112. PubMed ID: 30156539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood-onset of primary Sjögren's syndrome: phenotypic characterization at diagnosis of 158 children.
    Ramos-Casals M; Acar-Denizli N; Vissink A; Brito-Zerón P; Li X; Carubbi F; Priori R; Toplak N; Baldini C; Faugier-Fuentes E; Kruize AA; Mandl T; Tomiita M; Gandolfo S; Hashimoto K; Hernandez-Molina G; Hofauer B; Mendieta-Zerón S; Rasmussen A; Sandhya P; Sene D; Trevisani VFM; Isenberg D; Sundberg E; Pasoto SG; Sebastian A; Suzuki Y; Retamozo S; Xu B; Giacomelli R; Gattamelata A; Bizjak M; Bombardieri S; Loor-Chavez RE; Hinrichs A; Olsson P; Bootsma H; Lieberman SM;
    Rheumatology (Oxford); 2021 Oct; 60(10):4558-4567. PubMed ID: 33493333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic involvement in primary Sjogren's syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry).
    Ramos-Casals M; Brito-Zerón P; Solans R; Camps MT; Casanovas A; Sopeña B; Díaz-López B; Rascón FJ; Qanneta R; Fraile G; Pérez-Alvarez R; Callejas JL; Ripoll M; Pinilla B; Akasbi M; Fonseca E; Canora J; Nadal ME; de la Red G; Fernández-Regal I; Jiménez-Heredia I; Bosch JA; Ayala MD; Morera-Morales L; Maure B; Mera A; Ramentol M; Retamozo S; Kostov B; ;
    Rheumatology (Oxford); 2014 Feb; 53(2):321-31. PubMed ID: 24162151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for cardiovascular disease in primary Sjögren's syndrome (pSS): a 20-year follow-up study.
    Santos CS; Salgueiro RR; Morales CM; Castro CÁ; Álvarez ED
    Clin Rheumatol; 2023 Nov; 42(11):3021-3031. PubMed ID: 37402929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of anti-La/SSB antibodies in primary Sjögren's syndrome patients with combined positivity for anti-Ro/SSA and salivary gland biopsy.
    Cafaro G; Perricone C; Baldini C; Quartuccio L; Priori R; Carubbi F; Ferro F; Colafrancesco S; Bini V; De Vita S; Giacomelli R; Gerli R; Bartoloni E;
    Clin Exp Rheumatol; 2020; 38 Suppl 126(4):53-56. PubMed ID: 33095137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between autoantibody types and salivary gland hypofunction in patients with primary Sjögren's syndrome.
    Kim BE; Kwon JS; Choi JH; Park PG; Ahn HJ
    J Oral Pathol Med; 2023 Feb; 52(2):188-194. PubMed ID: 36183157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjögren's syndrome (pSS): a European multicentre study.
    Tzioufas AG; Wassmuth R; Dafni UG; Guialis A; Haga HJ; Isenberg DA; Jonsson R; Kalden JR; Kiener H; Sakarellos C; Smolen JS; Sutcliffe N; Vitali C; Yiannaki E; Moutsopoulos HM
    Ann Rheum Dis; 2002 May; 61(5):398-404. PubMed ID: 11959762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting Sjögren's syndrome in patients with recent-onset SLE.
    Hernández-Molina G; Zamora-Legoff T; Romero-Díaz J; Nuñez-Alvarez CA; Cárdenas-Velázquez F; Hernández-Hernández C; Calderillo ML; Marroquín M; Recillas-Gispert C; Ávila-Casado C; Sánchez-Guerrero J
    Rheumatology (Oxford); 2013 Aug; 52(8):1438-42. PubMed ID: 23594470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of separate detection of anti-Ro52, anti-Ro60 and anti-SSB/La reactivities in relation to diagnosis and phenotypes in primary Sjögren's syndrome.
    Deroo L; Achten H; De Boeck K; Genbrugge E; Bauters W; Roels D; Dochy F; Creytens D; Deprez J; Van den Bosch F; Elewaut D; Peene I
    Clin Exp Rheumatol; 2022 Dec; 40(12):2310-1317. PubMed ID: 36200940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Ro/SSA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjögren's syndrome.
    Toker E; Yavuz S; Direskeneli H
    Br J Ophthalmol; 2004 Mar; 88(3):384-7. PubMed ID: 14977774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome?
    Manthorpe R; Benoni C; Jacobsson L; Kirtava Z; Larsson A; Liedholm R; Nyhagen C; Tabery H; Theander E
    Ann Rheum Dis; 2000 Jan; 59(1):54-60. PubMed ID: 10627428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Sjögren's Syndrome Years Before Diagnosis and Identification of Patients With Early Onset and Severe Disease Course by Autoantibody Profiling.
    Theander E; Jonsson R; Sjöström B; Brokstad K; Olsson P; Henriksson G
    Arthritis Rheumatol; 2015 Sep; 67(9):2427-36. PubMed ID: 26109563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren's syndrome: examination of data from the UK Primary Sjögren's Syndrome Registry.
    Dumusc A; Ng WF; James K; Griffiths B; Price E; Pease C; Emery P; Lanyon P; Jones A; Bombardieri M; Sutcliffe N; Pitzalis C; Gupta M; McLaren J; Cooper A; Giles I; Isenberg D; Saravanan V; Coady D; Dasgupta B; McHugh N; Young-Min S; Moots R; Gendi N; Akil M; Barone F; Fisher B; Rauz S; Richards A; Bowman S
    Swiss Med Wkly; 2018; 148():w14588. PubMed ID: 29442344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe, life-threatening phenotype of primary Sjögren's syndrome: clinical characterisation and outcomes in 1580 patients (GEAS-SS Registry).
    Flores-Chávez A; Kostov B; Solans R; Fraile G; Maure B; Feijoo-Massó C; Rascón FJ; Pérez-Alvarez R; Zamora-Pasadas M; García-Pérez A; Lopez-Dupla M; Duarte-Millán MÁ; Ripoll M; Fonseca-Aizpuru E; Guisado-Vasco P; Pinilla B; de-la-Red G; Chamorro AJ; Morcillo C; Fanlo P; Soto-Cárdenas MJ; Retamozo S; Ramos-Casals M; Brito-Zerón P;
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):121-129. PubMed ID: 30156546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution.
    Quartuccio L; Baldini C; Bartoloni E; Priori R; Carubbi F; Corazza L; Alunno A; Colafrancesco S; Luciano N; Giacomelli R; Gerli R; Valesini G; Bombardieri S; De Vita S
    Autoimmun Rev; 2015 Nov; 14(11):1019-22. PubMed ID: 26162302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ro(SSA) and La(SSB) antibodies in the clinical spectrum of Sjögren's syndrome.
    Alexander EL; Hirsch TJ; Arnett FC; Provost TT; Stevens MB
    J Rheumatol; 1982; 9(2):239-46. PubMed ID: 7097683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nailfold capillaroscopic findings in primary Sjögren's syndrome with and without Raynaud's phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodies.
    Corominas H; Ortiz-Santamaría V; Castellví I; Moreno M; Morlà R; Clavaguera T; Erra A; Martínez-Pardo S; Ordóñez S; Santo P; Reyner P; González MJ; Codina O; Gelman MS; Juanola-Roura X; Olivé A; Torrente-Segarra V;
    Rheumatol Int; 2016 Mar; 36(3):365-9. PubMed ID: 26597492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.